Nanovesicles that directly attack tumors and promote sustained tumor killing by resident T cells could enhance the effectiveness of tumor immunotherapy.
Nanovesicles that directly attack tumors and promote sustained tumor killing by resident T cells could enhance the effectiveness of tumor immunotherapy.
Fitting hydrogels with aptamer-based ligands can open doors for a range of new biomedical applications.
“Brain-on-a-chip” shows minute-by-minute how the blood–brain barrier reacts to high levels of inflammation.
Researchers find the sweet spot between strength and biocompatibility in these tiny cell-carrying microrobots.
Large-scale recoding of virus genomes has the potential for use in vaccine design.
A minimally invasive method holds promise for the treatment of neurological disorders and injury.
Scientists are looking to improve the outlook for patients with bladder cancer by advancing a laser-based photothermal therapy.
With a long history of development, mRNA vaccines are finally making their debut and changing the face of the COVID-19 pandemic.
Small clinical trial has found that metabolic activators can improve recovery, liver health, and markers of inflammation in patients with COVID-19.
The device could improve personalized medicine by detecting whether a specific drug is likely to work for a patient before it is administered.